Jim Hoffman: New Potential Predictive Biomarker for Lupus Nephritis
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Lupus Foundation of America’s post on LinkedIn about a recent article by Eline Jana Arends et al., published in Lupus Science and Medicine, adding:
”I find it incomprehensible at this point, given all the evidence that NETs exacerbate flares, that they are not being routinely prognostically tracked in the clinic and treated to minimize the severity of Lupus flares that can accelerate irreversible tissue and organ damage, particularly as the severity of the condition worsens and becomes increasingly refractory to systemic drug treatments.
New Potential Predictive Biomarker for Lupus Nephritis
Abstract: NET load as a novel biomarker of autoimmune activity and flare risk in SLE
What better way to study the NET effect, not only as a predictive prognostic indicator but as a highly valued clinical theranostic/theragnostic marker for direct and potentially improved treatment using this extracorporeal NET removal therapy, which can most likely also be applied to the treatment of many other lupus-like autoimmune diseases/syndromes.”
Lupus Foundation of America shared a post on LinkedIn:
”A new study finds people with systemic autoimmune rheumatic diseases like lupus and clinicians describe flares differently, especially in how quickly they start, how they are recognized, and whether they require changes in treatment.”
Title: NET load as a novel biomarker of autoimmune activity and flare risk in SLE
Authors: Eline Jana Arends, Rudmer J Postma, Sandra Van Der Kooij, Sylvia WA Kamerling, Maarten Limper, Alexandre E Voskuijl, Karina De Leeuw, Luuk B Hillbrands, Johan H Van Der Vlag, Marc Bijl, Ton J Rabelink, Cees Van Kooten, YK Onno Teng

Other posts featuring Jim Hoffman on Hemostasis Today.
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation